JAZZ
NASDAQ · Pharmaceuticals
Jazz Pharmaceuticals Plc
$229.85
-0.40 (-0.17%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+34.81%
1Y
+114.57%
YTD
+32.75%
Open$229.76
Previous Close$230.25
Day High$234.08
Day Low$228.30
52W High$243.32
52W Low$105.00
Volume—
Avg Volume920.8K
Market Cap14.11B
P/E Ratio478.51
EPS$0.11
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$167.39
Above
SMA 200
$136.05
Above
RSI (14)
68.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
-19.0% upside
Current
$229.85
$229.85
Target
$186.25
$186.25
$114.97
$186.25 avg
$267.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.40B | 4.18B | 1.73B |
| Net Income | -366,873,810 | -313,686,518 | 500.28M |
| Profit Margin | -8.4% | -7.9% | 28.9% |
| EBITDA | 231.18M | 208.65M | 730.31M |
| Free Cash Flow | — | — | 376.40M |
| Rev Growth | +5.3% | +5.3% | +7.8% |
| Debt/Equity | 1.24 | 1.24 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |